SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/08/22 Medifast Inc. 8-K:8 9/08/22 12:230K Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 36K 2: EX-99.1 Miscellaneous Exhibit HTML 13K 7: R1 Cover HTML 49K 10: XML IDEA XML File -- Filing Summary XML 13K 8: XML XBRL Instance -- med-20220908_htm XML 25K 9: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.DEF XBRL Definitions -- med-20220908_def XML 44K 5: EX-101.LAB XBRL Labels -- med-20220908_lab XML 88K 6: EX-101.PRE XBRL Presentations -- med-20220908_pre XML 43K 3: EX-101.SCH XBRL Schema -- med-20220908 XSD 13K 11: JSON XBRL Instance as JSON Data -- MetaLinks 14± 21K 12: ZIP XBRL Zipped Folder -- 0001628280-22-024594-xbrl Zip 25K
med-20220908 |
i Delaware (State
or other jurisdiction of incorporation) | (Commission File Number) | i 13-3714405 (I.R.S.
Employer Identification No.) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
i Common
Stock, par value $0.001 per share | i MED | i New York Stock Exchange |
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Emerging growth company | i ☐ | ||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | o |
(d) | Exhibits. | |||||||
99.1 | ||||||||
104.1 | Cover Page Interactive Data File (embedded within the Inline XBRLDocument) |
MEDIFAST, INC. | ||||||||
By: | /s/ James P. Maloney | |||||||
James P. Maloney | ||||||||
Chief Financial Officer | ||||||||
Dated: September 8, 2022 |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 9/8/22 | None on these Dates | ||
List all Filings |